FDA OKs Dust Mite Allergy Drug for Young Kids

(MedPage Today) -- The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced.
Taken as a once-daily tablet, the SLIT product is now indicated for...